Whitepaper: Mutual recognition of inspections of medicinal product manufacturers between the EU and the USA

The first attempt for the EU and the USA to have a GMP MRA for medicinal products dates back to 1998, when the first MRA was signed between the two parties.


**For more information, please see Cencora PharmaLex Privacy Policy. If you do not wish to receive any communication from us, you may unsubscribe at any time.

First announced in March 2017, the mutual recognition agreement (MRA) for Good Manufacturing Practices (GMP) for medicinal products between the European Union (EU) and the United States of America (USA) is now fully implemented.

In this White Paper, we summarize the scope and the impact of this agreement on the pharmaceutical manufacturers and the authorities in both regions.

Download The free eBook